Erectile Dysfunction after Therapy with Metoprolol: The Hawthorne Effect

被引:63
作者
Cocco, G. [1 ]
机构
[1] Cardiol Off, CH-4310 Rheinfelden 1, Switzerland
关键词
Metoprolol; beta-Blockers; Erectile dysfunction; BETA-BLOCKERS; DISEASE;
D O I
10.1159/000147951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: It is often assumed that beta-blockers, e. g. metoprolol (METO), induce erectile dysfunction (ED) in men. However, cardiovascular diseases can also induce ED and there is also the possibility that psychological factors, such as fear of the disease and side effects of the prescribed drug, may also induce ED. Thus, it is often assumed that beta-blockers induce ED in a large percentage of men, but this statement is not well validated and the role of the pharmacologic effect of METO per se on the occurrence of ED is largely unknown. To get an answer we selected 114 men ( age 57 +/- 4.7 years) without ED but with newly diagnosed arterial hypertension, and who could be treated with METO. Methods: METO ( 100 mg/day) was given as a retard formulation. The hypertensive men were randomized into 3 groups. In group 1 patients were fully informed ( they knew that the drug was METO and that it might induce ED). In group 2 patients were partially informed ( they knew that the drug was METO, but were not informed that it might induce ED). In group 3 patients were not informed either about the drug used or about the possible occurrence of ED. The first phase of the study lasted 60 days. After 60 days the incidence of ED was 32% in group 1, 13% in group 2, and 8% in group 3 ( p < 0.01). All patients with ED entered the second, cross-over, double-blind phase of the study. METO was continued at unchanged dosage, and tadalafil (20 mg) and a placebo were given to treat ED. Results: Both treatments were equally effective. Conclusion: Prejudice about the possible occurrence, i.e. the Hawthorne effect, of ED with METO facilitates the occurrence of this side effect in hypertensive men. Since the etiology of this ED is largely psychological, it is not surprising that placebo is as effective as tadalafil in reversing of this side effect. Copyright (c) 2008 S. Karger AG, Basel
引用
收藏
页码:174 / 177
页数:4
相关论文
共 11 条
[1]  
DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
[2]   Effects of beta-blockers on sexual performance in men with coronary heart disease.: A prospective, randomized and double blinded study [J].
Franzen, D ;
Metha, A ;
Seifert, N ;
Braun, M ;
Höpp, HW .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2001, 13 (06) :348-351
[3]  
Gillespie R., 1991, Manufacturing knowledge: a history of the hawthorne experiments
[4]   Phosphodiesterase type 5 inhibition in erectile dysfunction: an overview [J].
Giuliano, F .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2002, 4 (0H) :H7-H12
[5]   Erectile dysfunction: a marker of silent coronary artery disease [J].
Jackson, Graham .
EUROPEAN HEART JOURNAL, 2006, 27 (22) :2613-2614
[6]  
Keene Louise C., 1999, Adverse Drug Reactions and Toxicological Reviews, V18, P5
[7]   New insights into erectile dysfunction: A practical approach [J].
Korenman, SG .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (02) :135-144
[8]   SEXUAL SEQUELAE OF ANTIHYPERTENSIVE DRUGS - TREATMENT EFFECTS ON SELF-REPORT AND PHYSIOLOGICAL MEASURES IN MIDDLE-AGED MALE HYPERTENSIVES [J].
ROSEN, RC ;
KOSTIS, JB ;
JEKELIS, A ;
TASKA, LS .
ARCHIVES OF SEXUAL BEHAVIOR, 1994, 23 (02) :135-152
[9]  
ROSEN RC, 1998, UROLOGY, V81, P424
[10]   Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo [J].
Silvestri, A ;
Galetta, P ;
Cerquetani, E ;
Marazzi, G ;
Patrizi, R ;
Fini, M ;
Rosano, GMC .
EUROPEAN HEART JOURNAL, 2003, 24 (21) :1928-1932